The Future of Advanced Prostate Management Presentation - Mark Rubin

[GranPaSmurf]

Mark Rubin presents on the future of metastatic prostate cancer in regards to biomarkers at the Advanced Prostate Cancer Consensus Conference (APCCC 2019). He discusses both predictive and prognostic biomarkers, currently used biomarker tests, and a summary of some of the many studied biomarkers that are ready and appear promising. In conclusion he shares his beliefs of what we now require which are to overcome heterogeneity by using a liquid biopsy to overcome the limits of biopsying multiple metastases and capturing heterogeneity and /or serial biopsies and the need to incorporate advanced biomarkers for advanced prostate cancer – these are non-invasive approaches to monitor the evolution of prostate cancer.

urotoday.com/video-lectures...